Easter Seals Jobs

The fellow will work with Dr. Chintan Dave, Assistant Professor of Pharmacy and Epidemiology at Rutgers School of Pharmacy and School of Public Health and core member within the Center for Pharmacoepidemiology and Treatment Science (PETS), answering high-impact questions to inform clinical decision making on the comparative safety and effectiveness of medications used for cardio-metabolic conditions.

This is a two-year position that is supported by active NIH and other funding mechanisms, with the anticipated start date of after September 2023. The successful candidate will further develop research skills under the mentorship of Dr. Dave and will have opportunities to develop their own research question, lead several impactful research studies, compose and submit their own grants, write, and publish in scientific journals, and continue their own scholarly and research development with input from PETS faculty, including Dr. Brian L. Strom. The fellow is expected to participate in international conferences and publish high-quality journal papers. Opportunities are also available for teaching experiences with the School of Public Health for courses taught by PETS faculty.

PETS was formed to create an interdisciplinary locus for world-class research and training in pharmacoepidemiology at Rutgers. Over the past 6 years, PETS has developed into a major research group, recruiting numerous new core, part-time, and adjunct faculty, and an experienced team of highly trained administrative and analytic staff. The current PETS core faculty have been funded by numerous R01s, K awards, and foundation awards. PETS faculty work on a variety of topics in pharmacoepidemiology and related fields, including traditional drug safety studies, comparative effectiveness research, pharmacoepidemiologic methods, clinical epidemiology, and health services research. They regularly collaborate with researchers across campus, across the US, and internationally, including colleagues from academia, industry, and government. Center faculty and trainees have access to a variety of national electronic health record and claims databases covering well over 120 million lives. PETS faculty members serve on FDA Advisory Committees, on study sections at the National Institutes of Health, committees at the National Academies of Science, Engineering, and Medicine, and in various roles within clinical and research organizations, particularly ISPE, where PETS faculty serve as current President and Incoming President-Elect, among numerous other leadership roles.

* A doctorate degree in pharmacoepidemiology, epidemiology, biostatistics or related fields
* Knowledge in pharmacoepidemiologic research methods and programming skills using SAS.
* Demonstrated oral and written communication skills, and the ability to present scientific findings in various formats and to compose manuscripts for publication in peer-reviewed journals.
* Ability to work well independently and in a collaborative team environment including research analysts, scientists, as well as other PETS trainees and faculty.
Excellent organizational, planning, project management, and problem solving skills.

* Develop and support the creation of scientific protocols and statistical analysis plans for grant funded and independent studies
* Conduct data analyses, interpret, and present study results with appropriate conclusions and/or recommendations relevant to research activity.
Participate in regular PETS research meetings, journal clubs, and study progress meetings

The Center for Pharmacoepidemiology and Treatment Science (PETS) facilitates and performs innovative, multidisciplinary science related to the use and outcomes of therapeutics and diagnostics in large populations. The mission of the center is to advance pharmacoepidemiology and related fields by conducting world-class research and facilitating high-quality training. PETS builds on strong existing faculty and research infrastructure and enjoys substantial support from Rutgers Biomedical and Health Science (RBHS). RBHS was created during the 2013 integration of the health professional schools from Rutgers University and the former University of Medicine and Dentistry of New Jersey. The eight schools, six centers and institutes and a behavioral health care network of RBHS collectively comprise one of America's largest, most comprehensive university-based centers for studying and improving human health and health care. The Institute for Health, RBHS, and the substantial resources of Rutgers University offer a rich collaborative environment for conducting pharmacoepidemiology and health services research. RBHS is home to Rutgers Health Group, New Jersey's largest multi-specialty medical group that includes the state's only NCI-designated comprehensive cancer center, a large behavioral health delivery system, and Robert Wood Johnson Partners, a commercial and Medicare ACO. RBHS partners with RWJBarnabas Health, the state's largest healthcare delivery system. Research among these units expands considerably the opportunities for researchers. The Institute for Health has faculty and other researchers with considerable expertise in pharmacoepidemiology the social and clinical sciences, health research and policy, public health, and related fields. Its faculty have exceptional capacity to address the most pressing health and healthcare challenges. Considerable strength exists in the analysis of large, integrated health-related clinical and administrative datasets, national surveys, and other data. Researchers within PETS and the Institute have great depth of expertise and experience in the analysis of Medicaid, Medicare, and private insurance data and the application of social science theory and advanced statistical techniques in large data sets.